The following is a review of diagnostic product developments worldwideThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.
The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Product developments in April 2004
Accumetrics has introduced its VerifyNow Aspirin test that measures platelet aggregation in a way that specifically tests for the effects of aspirin for aspirin responders or non-responders.
Calypte Biomedical Corporation has acquired a non-exclusive license for patented HIV-Type 1 and HIV-Type 2 ("HIV-1/2") peptides from Adaltis, Inc.
DiaSys Corporation has introduced its UriPrep tube designed to provide urine sediment volume standardization as recommended by the US National Committee for Clinical Laboratory Standards (NCCLS), without the use of expensive specialized pipettes. The UriPrep tube incorporates an insert which traps 1 mL of fluid in the bottom of the tube.
Beckman Coulter's Hybritech subsidiary is collaborating with GTx, Inc. to provide a test used in the evaluation of ACAPODENE for the reduction in the incidence of high grade prostatic intraepithelial neoplasia (PIN), a premalignant lesion that has the potential to progress to prostate cancer. Information resulting from this collaboration will be evaluated for use by Beckman Coulter to determine its usefulness in research, development and evaluation of assays for prostate disease.
IMGENEX has launched its SARS-N ELISA kit to quantitatively measure the presence of SARS nucleocapsid (SARS-N) protein in infected cells or serum. The kit is available for research use only.
Immucor Inc. has received FDA clearance to market its Galileo blood transfusion system, a fully automated instrument that runs all the routine blood bank tests including blood grouping, antibody screening, crossmatch and antibody identification.
Nymox Pharmaceutical Corporation is developing a method and device for using saliva to determine cholesterol levels.
Prionics AG has received permission from the U.S. Department of Agriculture (USDA) to market the Prionics BSE tests, Prionics-Check WESTERN, and Prionics-Check LIA. The tests will be distributed by Roche Diagnostics in the United States.
SeraCare Life Sciences, Inc. has acquired all of the assets of the BBI Diagnostics and BBI Biotech Research Laboratories divisions of Boston Biomedica, Inc.
Trinity Biotech plc has acquired the assets of Adaltis US, Inc for $3.5 million in cash. Adaltis US is the US distribution arm for Adaltis, Inc. Trinity also acquired the immunoassay business of Fitzgerald Industries International, Inc. $16 million.
Product developments - March 2004
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links
Send mail to email@example.com with questions or comments about this web site.
Concept and Design Blue Page
Last modified: May 03, 2004